Updates on HPV Vaccination
Cervical cancer still poses a significant global challenge. Developed countries have mitigated this challenge by the introduction of structured screening programmes and, more recently, the HPV vaccine. Countries that have successfully introduced national HPV vaccination programmes are on course for...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/13/2/243 |
_version_ | 1797443857829330944 |
---|---|
author | Ojone Illah Adeola Olaitan |
author_facet | Ojone Illah Adeola Olaitan |
author_sort | Ojone Illah |
collection | DOAJ |
description | Cervical cancer still poses a significant global challenge. Developed countries have mitigated this challenge by the introduction of structured screening programmes and, more recently, the HPV vaccine. Countries that have successfully introduced national HPV vaccination programmes are on course for cervical cancer elimination in a few decades. In developing countries that lack structured screening and HPV vaccination programmes, cervical cancer remains a major cause of morbidity and mortality. The HPV vaccine is key to addressing the disproportionate distribution of cervical cancer incidence, with much to be gained from increasing vaccine coverage and uptake globally. This review covers the history and science of the HPV vaccine, its efficacy, effectiveness and safety, and some of the considerations and challenges posed to the achievement of global HPV vaccination coverage and the consequent elimination of cervical cancer. |
first_indexed | 2024-03-09T13:03:09Z |
format | Article |
id | doaj.art-cac6889e39cc465baadc867664e18688 |
institution | Directory Open Access Journal |
issn | 2075-4418 |
language | English |
last_indexed | 2024-03-09T13:03:09Z |
publishDate | 2023-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Diagnostics |
spelling | doaj.art-cac6889e39cc465baadc867664e186882023-11-30T21:52:00ZengMDPI AGDiagnostics2075-44182023-01-0113224310.3390/diagnostics13020243Updates on HPV VaccinationOjone Illah0Adeola Olaitan1Women’s Cancer Department, EGA Institute for Women’s Health, University College London, London WC1E 6BT, UKWomen’s Cancer Department, EGA Institute for Women’s Health, University College London, London WC1E 6BT, UKCervical cancer still poses a significant global challenge. Developed countries have mitigated this challenge by the introduction of structured screening programmes and, more recently, the HPV vaccine. Countries that have successfully introduced national HPV vaccination programmes are on course for cervical cancer elimination in a few decades. In developing countries that lack structured screening and HPV vaccination programmes, cervical cancer remains a major cause of morbidity and mortality. The HPV vaccine is key to addressing the disproportionate distribution of cervical cancer incidence, with much to be gained from increasing vaccine coverage and uptake globally. This review covers the history and science of the HPV vaccine, its efficacy, effectiveness and safety, and some of the considerations and challenges posed to the achievement of global HPV vaccination coverage and the consequent elimination of cervical cancer.https://www.mdpi.com/2075-4418/13/2/243human papillomavirusHPVHPV vaccinecervical cancer |
spellingShingle | Ojone Illah Adeola Olaitan Updates on HPV Vaccination Diagnostics human papillomavirus HPV HPV vaccine cervical cancer |
title | Updates on HPV Vaccination |
title_full | Updates on HPV Vaccination |
title_fullStr | Updates on HPV Vaccination |
title_full_unstemmed | Updates on HPV Vaccination |
title_short | Updates on HPV Vaccination |
title_sort | updates on hpv vaccination |
topic | human papillomavirus HPV HPV vaccine cervical cancer |
url | https://www.mdpi.com/2075-4418/13/2/243 |
work_keys_str_mv | AT ojoneillah updatesonhpvvaccination AT adeolaolaitan updatesonhpvvaccination |